Changes in levels of IL-9, IL-17, IFN-γ, dendritic cell numbers and TLR expression in peripheral blood in asthmatic children with Mycoplasma pneumoniae infection

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 5, 2015, Pages 5263-5272

  Shao, Li ^a   Cong, Zhijie ^a   Li, Xiaoli ^a   Zou, Hanbing ^a   Cao, Lanfang ^a   Guo, Yinshi ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Childhood asthma; Cytokines; Dendritic cell; Mycoplasma pneumoniae infection; T helper cell; Toll like receptor

Indexed keywords

AUTACOID; BIOLOGICAL MARKER; GAMMA INTERFERON; IFNG PROTEIN, HUMAN; IL9 PROTEIN, HUMAN; IMMUNOGLOBULIN E; INTERLEUKIN 17; INTERLEUKIN 9; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

AGE; ASTHMA; BLOOD; CASE CONTROL STUDY; CELL COUNT; CHILD; DENDRITIC CELL; FEMALE; HELPER CELL; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MICROBIOLOGY; MYCOPLASMA PNEUMONIAE; PATHOGENICITY; PNEUMONIA, MYCOPLASMA; PRESCHOOL CHILD; SKIN TEST;

AGE FACTORS; ASTHMA; BIOMARKERS; CASE-CONTROL STUDIES; CELL COUNT; CHILD; CHILD, PRESCHOOL; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNOGLOBULIN E; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-9; MALE; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; SKIN TESTS; T-LYMPHOCYTES, HELPER-INDUCER; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84937953575     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Biscardi S, Lorrot M, Marc E, Moulin F, Boutonnat-Faucher B, Heilbronner C, Iniguez JL, Chaussain M, Nicand E and Raymond J. Mycoplasma pneumoniae and asthma in children. Clin Infect Dis 2004; 38: 1341-1346.
2. Johnston SL and Martin RJ. Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis? Am J Respir Crit Care Med 2005; 172: 1078-1089.
3. Kraft M, Cassell GH, Henson JE, Watson H, Williamson J, Marmion B, Gaydos CA and Martin RJ. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med 1998; 158: 998-1001.
4. Sharavin AO and Smirnova SV. [Mycoplasma and Chlamydia as ethiological factors of bronchial asthma in terms of ethnogenesis]. Vestn Ross Akad Med Nauk 2013; 57-60.
5. Wood PR, Hill VL, Burks ML, Peters JI, Singh H, Kannan TR, Vale S, Cagle MP, Principe MF, Baseman JB and Brooks EG. Mycoplasma pneumoniae in children with acute and refractory asthma. Ann Allergy Asthma Immunol 2013; 110: 328-334 e321.
6. Nisar N, Guleria R, Kumar S, Chawla TC and Biswas NR. Mycoplasma pneumoniae and its role in asthma. Postgrad Med J 2007; 83: 100-104.
7. Cosentini R, Tarsia P, Canetta C, Graziadei G, Brambilla AM, Aliberti S, Pappalettera M, Tantardini F and Blasi F. Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection. Respir Res 2008; 9: 1.
8. Park SJ, Lee YC, Rhee YK and Lee HB. Seroprevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in stable asthma and chronic obstructive pulmonary disease. J Korean Med Sci 2005; 20: 225-228.
9. Chen GD and Chen AH. [The wheezing associated with Mycoplasma pneumoniae infection in children]. Zhonghua Er Ke Za Zhi 2012; 50: 756-758, 759.
10. Hong SJ. The Role of Mycoplasma pneumoniae Infection in Asthma. Allergy Asthma Immunol Res 2012; 4: 59-61.
11. Wang Y, Zhu Z, Church TD, Lugogo NL, Que LG, Francisco D, Ingram JL, Huggins M, Beaver DM, Wright JR and Kraft M. SHP-1 as a critical regulator of Mycoplasma pneumoniae-induced inflammation in human asthmatic airway epithelial cells. J Immunol 2012; 188: 3371-3381.
12. Manuyakorn W. Airway remodelling in asthma: role for mechanical forces. Asia Pac Allergy 2014; 4: 19-24.
13. Endo Y, Hirahara K, Yagi R, Tumes DJ and Nakayama T. Pathogenic memory type Th2 cells in allergic inflammation. Trends Immunol 2014; 35: 69-78.
14. Antoniu SA. MEDI-528, an anti-IL-9 humanized antibody for the treatment of asthma. Curr Opin Mol Ther 2010; 12: 233-239.
15. Hauber HP, Bergeron C and Hamid Q. IL-9 in allergic inflammation. Int Arch Allergy Immunol 2004; 134: 79-87.
16. Cheng G, Arima M, Honda K, Hirata H, Eda F, Yoshida N, Fukushima F, Ishii Y and Fukuda T. Anti-Interleukin-9 Antibody Treatment Inhibits Airway Inflammation and Hyperreactivity in Mouse Asthma Model. Am J Respir Crit Care Med 2002; 166: 409-416.
17. Elias JA, Lee CG, Zheng T, Ma B, Homer RJ and Zhu Z. New insights into the pathogenesis of asthma. J Clin Invest 2003; 111: 291-297.
18. van den Brule S, Heymans J, Havaux X, Renauld JC, Lison D, Huaux F and Denis O. Profibrotic effect of IL-9 overexpression in a model of airway remodeling. Am J Respir Cell Mol Biol 2007; 37: 202-209.
19. Agache I, Ciobanu C, Agache C and Anghel M. Increased serum IL-17 is an independent risk factor for severe asthma. Respir Med 2010; 104: 1131-1137.
20. Liu J, Harberts E, Tammaro A, Girardi N, Filler RB, Fishelevich R, Temann A, Licona-Limon P, Girardi M, Flavell RA and Gaspari AA. IL-9 Regulates Allergen-Specific Th1 Responses in Allergic Contact Dermatitis. J Invest Dermatol 2014; 134: 1903-11.
21. Hammad H and Lambrecht BN. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat Rev Immunol 2008; 8: 193-204.
22. Lambrecht BN and Hammad H. Taking our breath away: dendritic cells in the pathogenesis of asthma. Nat Rev Immunol 2003; 3: 994-1003.
23. Iwasaki A and Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004; 5: 987-995.
24. Redecke V, Häcker H, Datta SK, Fermin A, Pitha PM, Broide DH and Raz E. Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 2004; 172: 2739-2743.
25. Daxboeck F, Krause R and Wenisch C. Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin Microbiol Infect 2003; 9: 263-273.
26. Lemanske RF Jr. Is asthma an infectious disease?: Thomas A. Neff lecture. Chest 2003; 123: 385S-390S.
27. Papadopoulos NG, Christodoulou I, Rohde G, Agache I, Almqvist C, Bruno A, Bonini S, Bont L, Bossios A, Bousquet J, Braido F, Brusselle G, Canonica GW, Carlsen KH, Chanez P, Fokkens WJ, Garcia-Garcia M, Gjomarkaj M, Haahtela T, Holgate ST, Johnston SL, Konstantinou G, Kowalski M, Lewandowska-Polak A, Lodrup-Carlsen K, Makela M, Malkusova I, Mullol J, Nieto A, Eller E, Ozdemir C, Panzner P, Popov T, Psarras S, Roumpedaki E, Rukhadze M, Stipic-Markovic A, Todo Bom A, Toskala E, van Cauwenberge P, van Drunen C, Watelet JB, Xatzipsalti M, Xepapadaki P and Zuberbier T. Viruses and bacteria in acute asthma exacerbations-a GA(2) LEN-DARE systematic review. Allergy 2011; 66: 458-468.
28. Metz G and Kraft M. Effects of atypical infections with Mycoplasma and Chlamydia on asthma. Immunol Allergy Clin North Am 2010; 30: 575-585, vii-viii.
29. Blanchard E and Raherison C. [Asthma and Mycoplasma pneumoniae]. Rev Mal Respir 2010; 27: 890-897.
30. Hernando-Sastre V. Macrolide antibiotics in the treatment of asthma. An update. Allergol Immunopathol (Madr) 2010; 38: 92-98.
31. Jeong YC, Yeo MS, Kim JH, Lee HB and Oh JW. Mycoplasma pneumoniae Infection Affects the Serum Levels of Vascular Endothelial Growth Factor and Interleukin-5 in Atopic Children. Allergy Asthma Immunol Res 2012; 4: 92-97.
32. Hassan J, Irwin F, Dooley S and Connell J. Mycoplasma pneumoniae infection in a pediatric population: analysis of soluble immune markers as risk factors for asthma. Hum Immunol 2008; 69: 851-855.
33. Shen C, Hupin C, Froidure A, Detry B and Pilette C. Impaired ICOSL in human myeloid dendritic cells promotes Th2 responses in patients with allergic rhinitis and asthma. Clin Exp Allergy 2014; 44: 831-41.
34. Dua B, Tang W, Watson R, Gauvreau G and O'Byrne P. Myeloid Dendritic Cells Type 2 After Allergen Inhalation In Asthmatic Subjects. Clin Exp Allergy 2014; 44: 921-9.
35. Kim E, Hong HJ, Cho D, Han JM, Kim S and Kim TS. Enhancement of toll-like receptor 2-mediated immune responses by AIMP1, a novel cytokine, in mouse dendritic cells. Immunology 2011; 134: 73-81.
36. Zhu X, Shi L, Schmidt MS, Boisen A, Hansen O, Zi J, Xiao S and Mortensen NA. Enhanced light-matter interactions in graphene-covered gold nanovoid arrays. Nano Lett 2013; 13: 4690-4696.
37. Heine H and Lien E. Toll-like receptors and their function in innate and adaptive immunity. Int Arch Allergy Immunol 2003; 130: 180-192.
38. Panzer R, Blobel C, Folster-Holst R and Proksch E. TLR2 and TLR4 expression in atopic dermatitis, contact dermatitis and psoriasis. Exp Dermatol 2014; 23: 364-6.
39. Shikhagaie MM, Andersson CK, Mori M, Kortekaas Krohn I, Bergqvist A, Dahl R, Ekblad E, Hoffmann HJ, Bjermer L and Erjefalt JS. Mapping of TLR5 and TLR7 in central and distal human airways and identification of reduced TLR expression in severe asthma. Clin Exp Allergy 2014; 44: 184-196.
40. Koponen P, Vuononvirta J, Nuolivirta K, Helminen M, He Q and Korppi M. The Association of Genetic Variants in Toll-Like Receptor 2 Subfamily with Allergy and Asthma after Hospitalization for Bronchiolitis in Infancy. Pediatr Infect Dis J 2014; 33: 463-6.
41. Love W, Dobbs N, Tabor L and Simecka JW. Toll-like receptor 2 (TLR2) plays a major role in innate resistance in the lung against murine Mycoplasma. PLoS One 2010; 5: e10739.
42. Schmitt E, Klein M and Bopp T. Th9 cells, new players in adaptive immunity. Trends Immunol 2014; 35: 61-68.
43. Kaplan MH. Th9 cells: differentiation and disease. Immunol Rev 2013; 252: 104-115.
44. Zhao P, Xiao X, Ghobrial RM and Li XC. IL-9 and Th9 cells: progress and challenges. Int Immunol 2013; 25: 547-551.
45. Li H and Rostami A. IL-9: basic biology, signaling pathways in CD4+ T cells and implications for autoimmunity. J Neuroimmune Pharmacol 2010; 5: 198-209.
46. Xing J, Wu Y and Ni B. Th9: a new player in asthma pathogenesis? J Asthma 2011; 48: 115-125.
47. Lee KE, Kim KW, Hong JY, Kim KE and Sohn MH. Modulation of IL-8 boosted by Mycoplasma pneumoniae lysate in human airway epithelial cells. J Clin Immunol 2013; 33: 1117-1125.